The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancer

Small molecule inhibitors of epidermal growth factor receptor (EGFR) tyrosine kinase activity, such as erlotinib and gefitinib, revolutionized therapy for non-small cell lung cancer (NSCLC) patients whose tumors harbor activating EGFR mutations. However, mechanisms to overcome the invariable develop...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Target Oncol
Main Authors: Smith, Donald L., Acquaviva, Jaime, Sequeira, Manuel, Jimenez, John-Paul, Zhang, Chaohua, Sang, Jim, Bates, Richard C., Proia, David A.
Format: Artigo
Sprog:Inglês
Udgivet: Springer International Publishing 2014
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4457934/
https://ncbi.nlm.nih.gov/pubmed/25077897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-014-0329-6
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker